Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2020

  • RnM4099347
  • |
  • 18 July, 2020
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Continuous Subcutaneous Insulin Infusion Devices is a medical device used for the administration of insulin in the treatment of diabetes mellitus
The global Continuous Subcutaneous Insulin Infusion Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
This report focuses on Continuous Subcutaneous Insulin Infusion Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Continuous Subcutaneous Insulin Infusion Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Continuous Subcutaneous Insulin Infusion Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Continuous Subcutaneous Insulin Infusion Devices Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China and Japan. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Continuous Subcutaneous Insulin Infusion Devices Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
Normal Pump
Patch Pump
By Application:
Type I Diabetes
Type II Diabetes
Key Players:
The Key manufacturers that are operating in the global Continuous Subcutaneous Insulin Infusion Devices market are:
Medtronic
Roche
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL
Microport
...
Competitive Landscape
The analysts have provided a comprehensive analysis of the competitive landscape of the global Continuous Subcutaneous Insulin Infusion Devices market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.


1 Continuous Subcutaneous Insulin Infusion Devices Market Overview

  • 1.1 Product Overview and Scope of Continuous Subcutaneous Insulin Infusion Devices
  • 1.2 Continuous Subcutaneous Insulin Infusion Devices Segment by Type
    • 1.2.1 Global Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate Comparison by Type 2020 VS 2026
    • 1.2.2 Normal Pump
    • 1.2.3 Patch Pump
  • 1.3 Continuous Subcutaneous Insulin Infusion Devices Segment by Application
    • 1.3.1 Continuous Subcutaneous Insulin Infusion Devices Consumption Comparison by Application: 2020 VS 2026
    • 1.3.2 Type I Diabetes
    • 1.3.3 Type II Diabetes
  • 1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market by Region
    • 1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size Estimates and Forecasts by Region: 2020 VS 2026
    • 1.4.2 North America Estimates and Forecasts (2015-2026)
    • 1.4.3 Europe Estimates and Forecasts (2015-2026)
    • 1.4.4 China Estimates and Forecasts (2015-2026)
    • 1.4.5 Japan Estimates and Forecasts (2015-2026)
  • 1.5 Global Continuous Subcutaneous Insulin Infusion Devices Growth Prospects
    • 1.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Estimates and Forecasts (2015-2026)
    • 1.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity Estimates and Forecasts (2015-2026)
    • 1.5.3 Global Continuous Subcutaneous Insulin Infusion Devices Production Estimates and Forecasts (2015-2026)
  • 1.6 Continuous Subcutaneous Insulin Infusion Devices Industry
  • 1.7 Continuous Subcutaneous Insulin Infusion Devices Market Trends

2 Market Competition by Manufacturers

  • 2.1 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity Market Share by Manufacturers (2015-2020)
  • 2.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Share by Manufacturers (2015-2020)
  • 2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Continuous Subcutaneous Insulin Infusion Devices Average Price by Manufacturers (2015-2020)
  • 2.5 Manufacturers Continuous Subcutaneous Insulin Infusion Devices Production Sites, Area Served, Product Types
  • 2.6 Continuous Subcutaneous Insulin Infusion Devices Market Competitive Situation and Trends
    • 2.6.1 Continuous Subcutaneous Insulin Infusion Devices Market Concentration Rate
    • 2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Continuous Subcutaneous Insulin Infusion Devices Market Share by Regions (2015-2020)
  • 3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Regions (2015-2020)
  • 3.3 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.4 North America Continuous Subcutaneous Insulin Infusion Devices Production
    • 3.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2015-2020)
    • 3.4.2 North America Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.5 Europe Continuous Subcutaneous Insulin Infusion Devices Production
    • 3.5.1 Europe Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2015-2020)
    • 3.5.2 Europe Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.6 China Continuous Subcutaneous Insulin Infusion Devices Production
    • 3.6.1 China Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2015-2020)
    • 3.6.2 China Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
  • 3.7 Japan Continuous Subcutaneous Insulin Infusion Devices Production
    • 3.7.1 Japan Continuous Subcutaneous Insulin Infusion Devices Production Growth Rate (2015-2020)
    • 3.7.2 Japan Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Continuous Subcutaneous Insulin Infusion Devices Consumption by Regions

  • 4.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption by Regions
    • 4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption by Region
    • 4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Continuous Subcutaneous Insulin Infusion Devices Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Continuous Subcutaneous Insulin Infusion Devices Consumption by Countries
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Continuous Subcutaneous Insulin Infusion Devices Production, Revenue, Price Trend by Type

  • 5.1 Global Continuous Subcutaneous Insulin Infusion Devices Production Market Share by Type (2015-2020)
  • 5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2015-2020)
  • 5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2015-2020)
  • 5.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Continuous Subcutaneous Insulin Infusion Devices Market Analysis by Application

  • 6.1 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Market Share by Application (2015-2020)
  • 6.2 Global Continuous Subcutaneous Insulin Infusion Devices Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Continuous Subcutaneous Insulin Infusion Devices Business

  • 7.1 Medtronic
    • 7.1.1 Medtronic Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.1.2 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.1.4 Medtronic Main Business and Markets Served
  • 7.2 Roche
    • 7.2.1 Roche Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.2.2 Roche Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.2.4 Roche Main Business and Markets Served
  • 7.3 Insulet Corp
    • 7.3.1 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.3.2 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.3.4 Insulet Corp Main Business and Markets Served
  • 7.4 Tandem Diabetes care
    • 7.4.1 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.4.2 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.4.4 Tandem Diabetes care Main Business and Markets Served
  • 7.5 Valeritas
    • 7.5.1 Valeritas Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.5.2 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.5.4 Valeritas Main Business and Markets Served
  • 7.6 SOOIL
    • 7.6.1 SOOIL Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.6.2 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.6.4 SOOIL Main Business and Markets Served
  • 7.7 Microport
    • 7.7.1 Microport Continuous Subcutaneous Insulin Infusion Devices Production Sites and Area Served
    • 7.7.2 Microport Continuous Subcutaneous Insulin Infusion Devices Product Introduction, Application and Specification
    • 7.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)
    • 7.7.4 Microport Main Business and Markets Served

8 Continuous Subcutaneous Insulin Infusion Devices Manufacturing Cost Analysis

  • 8.1 Continuous Subcutaneous Insulin Infusion Devices Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
  • 8.4 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Continuous Subcutaneous Insulin Infusion Devices Distributors List
  • 9.3 Continuous Subcutaneous Insulin Infusion Devices Customers

10 Market Dynamics

  • 10.1 Market Trends
  • 10.2 Opportunities and Drivers
  • 10.3 Challenges
  • 10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Continuous Subcutaneous Insulin Infusion Devices (2021-2026)
  • 11.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices (2021-2026)
  • 11.3 Global Forecasted Price of Continuous Subcutaneous Insulin Infusion Devices (2021-2026)
  • 11.4 Global Continuous Subcutaneous Insulin Infusion Devices Production Forecast by Regions (2021-2026)
    • 11.4.1 North America Continuous Subcutaneous Insulin Infusion Devices Production, Revenue Forecast (2021-2026)
    • 11.4.2 Europe Continuous Subcutaneous Insulin Infusion Devices Production, Revenue Forecast (2021-2026)
    • 11.4.3 China Continuous Subcutaneous Insulin Infusion Devices Production, Revenue Forecast (2021-2026)
    • 11.4.4 Japan Continuous Subcutaneous Insulin Infusion Devices Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted and Consumption Demand Analysis of Continuous Subcutaneous Insulin Infusion Devices
  • 12.2 North America Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Devices by Country
  • 12.3 Europe Market Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Devices by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Devices by Regions
  • 12.5 Latin America Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Devices

13 Forecast by Type and by Application (2021-2026)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
    • 13.1.1 Global Forecasted Production of Continuous Subcutaneous Insulin Infusion Devices by Type (2021-2026)
    • 13.1.2 Global Forecasted Revenue of Continuous Subcutaneous Insulin Infusion Devices by Type (2021-2026)
    • 13.1.2 Global Forecasted Price of Continuous Subcutaneous Insulin Infusion Devices by Type (2021-2026)
  • 13.2 Global Forecasted Consumption of Continuous Subcutaneous Insulin Infusion Devices by Application (2021-2026)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Continuous Subcutaneous Insulin Infusion Devices. Industry analysis & Market Report on COVID-19 Impact on Global Continuous Subcutaneous Insulin Infusion Devices is a syndicated market report, published as COVID-19 Impact on Global Continuous Subcutaneous Insulin Infusion Devices Market Research Report 2020. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Continuous Subcutaneous Insulin Infusion Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,500.00
    $7,000.00
    2,796.50
    5,593.00
    3,251.50
    6,503.00
    545,335.00
    1,090,670.00
    292,390.00
    584,780.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report